SPY380.36-1.97 -0.52%
DIA309.45-4.53 -1.44%
IXIC13,192.35+72.96 0.56%

DJ Bolt Biotherapeutics Upsized IPO Priced Above Increased Expectations >BOLT

· 02/05/2021 05:58

By Colin Kellaher

Bolt Biotherapeutics Inc. said its upsized initial public offering of 11.5 million shares was priced at $20 apiece, above already increased expectations.

The Redwood City, Calif., clinical-stage immuno-oncology company previously raised the size and price range of the offering to 10.5 million shares at $18 to $19 each from earlier plans to sell about 8.83 million shares at between $16 and $18.

Bolt said it granted the underwriters a 30-day option to buy up to an additional 1.73 million shares.

Bolt shares are slated to begin trading Friday under the symbol BOLT.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

February 05, 2021 05:58 ET (10:58 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.